NCT01309061View on ClinicalTrials.gov

The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

February 28, 2010

Conditions
Progressive Hemifacial AtrophyRomberg's Disease
Interventions
PROCEDURE

Autologous Adipose Tissue derived MSCs Transplantation

Intramuscular infusion of Autologous Adipose Tissue derived MSCs with autologous microlipoinjection. Dose: 1x10e7 cells/500ul/lipoinjection 20ml

Trial Locations (1)

Unknown

ASAN Medical Center, Seoul

Sponsors

Lead Sponsor

R-Bio

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

R-Bio

INDUSTRY

NCT01309061 - The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease | Biotech Hunter | Biotech Hunter